soul trial oral semaglutide cardiovascular outcomes 2024 results mace reduction A emulation in Nature Medicine shows that treatment with and tirzepatide showed similar levels of benefit on in people at elevated cardiovascular risk with obesity and diabetes. Link SOUL (Semaglutide cardiOvascular oUtcomes triaL)
Description
To reduce joint pain, regain mobility, and support long-term healing, Tirzepatide may be an ideal first step
5.6% placebo)
It wont take more than a few minutes.
The threat is real but manageable
There is no cost to attend
Side Effects: What to Expect with Each Since both medications work through similar mechanisms, they cause similar side effects
